| Drug Name |
Cefaclor |
| Drug ID |
BADD_D00378 |
| Description |
Semisynthetic, broad-spectrum antibiotic derivative of cephalexin. |
| Indications and Usage |
For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections. |
| Marketing Status |
approved |
| ATC Code |
J01DC04 |
| DrugBank ID |
DB00833
|
| KEGG ID |
D00256; D02352
|
| MeSH ID |
D002433
|
| PubChem ID |
51039
|
| TTD Drug ID |
D0PW7C
|
| NDC Product Code |
0093-1087; 23594-250; 23594-375; 23594-125; 61442-171; 61442-172; 81948-6250 |
| UNII |
69K7K19H4L
|
| Synonyms |
Cefaclor | Cefaclor Anhydrous | Keclor | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))- | S-6472 | S 6472 | S6472 | Ceclor | Cefaclor Monohydrate | Lilly 99638 |
